Vaxart, Inc. (VXRT)

NASDAQ: VXRT · Real-Time Price · USD

0.4673

+0.0173 (3.84%)

At close: May 29, 2025, 4:00 PM

0.4603

-0.0071 (-1.51%)

After-hours: May 29, 2025, 7:58 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Oral Recombinant Protein Vaccines	7.38M	Log In	Log In	Log In	Log In	Upgrade
Oral Recombinant Protein Vaccines Growth	6796.26%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	7.38M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	6796.26%	Log In	Log In	Log In	Log In	Upgrade